A Phase 1 Food Effect Study of TAK-536TCH Final Formulation Tablet
NCT02348658
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
12
Enrollment
INDUSTRY
Sponsor class
Conditions
Hypertension
Interventions
DRUG:
TAK-536TCH
Sponsor
Takeda